Concepedia

Gordon Bruton

GB

Statistics

Publications

9

Citations

325

H-Index

9

Active since

1970

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Age UK

University of Southampton

GlaxoSmithKline (United States)

Gordon Bruton is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, drug discovery, and medicinal chemistry.

Publications per year

1970–2022

9

Publications

9

Inhibitors of Bacterial Signal Peptidases

M. BLACK, Gordon Bruton · Current Pharmaceutical Design · 1970 · 65 citations

Life Sciences, Biochemistry, Microbiology +17

Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats

Andrew D. Medhurst, Michael A. Briggs, Gordon Bruton et al. · Biochemical Pharmacology · 2007 · 64 citations

Life Sciences, Neuroscience, Pharmacology +12

Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to α-ketoamide inhibitors

Gordon Bruton, Anthony Huxley, Peter J. O’Hanlon et al. · European Journal of Medicinal Chemistry · 2003 · 52 citations

Life Sciences, Biochemistry, Molecular Biology +11

6-(Substituted methylene)penems, potent broad spectrum inhibitors of bacterial .BETA.-lactamase. III. Structure-activity relationships of the 5-membered heterocyclic derivatives.

ISABEL S. BENNETT, N. J. P. BROOM, Gordon Bruton et al. · The Journal of Antibiotics · 1991 · 44 citations · Full text

Pharmacy, Chemistry, Medicinal Chemistry +17

An efficient synthesis of endo,exo-furofuranone derivatives

Nigel A. Swain, Richard C. D. Brown, Gordon Bruton · Chemical Communications · 2002 · 24 citations

Natural Sciences, Chemistry, Medicinal Chemistry +17

1–5 of 9